157 related articles for article (PubMed ID: 21145749)
1. Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation.
Veerapen N; Reddington F; Salio M; Cerundolo V; Besra GS
Bioorg Med Chem; 2011 Jan; 19(1):221-8. PubMed ID: 21145749
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of alpha-galactosyl ceramide (KRN7000) and analogues thereof via a common precursor and their preliminary biological assessment.
Michieletti M; Bracci A; Compostella F; De Libero G; Mori L; Fallarini S; Lombardi G; Panza L
J Org Chem; 2008 Nov; 73(22):9192-5. PubMed ID: 18956839
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of hydroxylated analogues of KRN7000 (α-galactosylceramide).
Shiozaki M; Tashiro T; Koshino H; Shigeura T; Watarai H; Taniguchi M; Mori K
Carbohydr Res; 2013 Apr; 370():46-66. PubMed ID: 23454137
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro evaluation of alpha-GalCer epimers.
Trappeniers M; Goormans S; Van Beneden K; Decruy T; Linclau B; Al-Shamkhani A; Elliott T; Ottensmeier C; Werner JM; Elewaut D; Van Calenbergh S
ChemMedChem; 2008 Jul; 3(7):1061-70. PubMed ID: 18418814
[TBL] [Abstract][Full Text] [Related]
5. Novel synthesis of alpha-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity.
Lee A; Farrand KJ; Dickgreber N; Hayman CM; Jürs S; Hermans IF; Painter GF
Carbohydr Res; 2006 Dec; 341(17):2785-98. PubMed ID: 17014832
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of alpha-galactosyl ceramide KRN7000 and galactosyl (alpha1-->2) galactosyl ceramide.
Veerapen N; Brigl M; Garg S; Cerundolo V; Cox LR; Brenner MB; Besra GS
Bioorg Med Chem Lett; 2009 Aug; 19(15):4288-91. PubMed ID: 19502056
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of alpha-L-fucosyl ceramides, analogues of the potent agonist, alpha-D-galactosyl ceramide KRN7000.
Veerapen N; Reddington F; Bricard G; Porcelli SA; Besra GS
Bioorg Med Chem Lett; 2010 Jun; 20(11):3223-6. PubMed ID: 20462758
[TBL] [Abstract][Full Text] [Related]
8. New CD1d agonists: synthesis and biological activity of 6″-triazole-substituted α-galactosyl ceramides.
Jervis PJ; Graham LM; Foster EL; Cox LR; Porcelli SA; Besra GS
Bioorg Med Chem Lett; 2012 Jul; 22(13):4348-52. PubMed ID: 22652050
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of sphinganine analogues of KRN7000 and OCH.
Ndonye RM; Izmirian DP; Dunn MF; Yu KO; Porcelli SA; Khurana A; Kronenberg M; Richardson SK; Howell AR
J Org Chem; 2005 Dec; 70(25):10260-70. PubMed ID: 16323834
[TBL] [Abstract][Full Text] [Related]
10. Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production.
Wojno J; Jukes JP; Ghadbane H; Shepherd D; Besra GS; Cerundolo V; Cox LR
ACS Chem Biol; 2012 May; 7(5):847-55. PubMed ID: 22324848
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of α-galactosylceramide analogues with heteroaromatic rings and varying positions of a phenyl group in the sphingosine backbone.
Kim Y; Oh K; Song H; Lee DS; Park SB
J Med Chem; 2013 Sep; 56(17):7100-9. PubMed ID: 23919244
[TBL] [Abstract][Full Text] [Related]
12. A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells.
Liu Y; Goff RD; Zhou D; Mattner J; Sullivan BA; Khurana A; Cantu C; Ravkov EV; Ibegbu CC; Altman JD; Teyton L; Bendelac A; Savage PB
J Immunol Methods; 2006 May; 312(1-2):34-9. PubMed ID: 16647712
[TBL] [Abstract][Full Text] [Related]
13. RCAI-8, 9, 18, 19, and 49-52, conformationally restricted analogues of KRN7000 with an azetidine or a pyrrolidine ring: Their synthesis and bioactivity for mouse natural killer T cells to produce cytokines.
Fuhshuku K; Hongo N; Tashiro T; Masuda Y; Nakagawa R; Seino K; Taniguchi M; Mori K
Bioorg Med Chem; 2008 Jan; 16(2):950-64. PubMed ID: 17950609
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists.
Guillaume J; Pauwels N; Aspeslagh S; Zajonc DM; Elewaut D; Van Calenbergh S
Bioorg Med Chem; 2015 Jul; 23(13):3175-82. PubMed ID: 26003341
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of an acyl-chain unsaturated analog of the Th2 biasing, immunostimulatory glycolipid, OCH.
Velmourougane G; Raju R; Bricard G; Im JS; Besra GS; Porcelli SA; Howell AR
Bioorg Med Chem Lett; 2009 Jul; 19(13):3386-8. PubMed ID: 19481452
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activities of amino acids functionalized α-GalCer analogues.
Ma W; Bi J; Zhao C; Zhang Z; Liu T; Zhang G
Bioorg Med Chem; 2020 Jan; 28(1):115141. PubMed ID: 31786009
[TBL] [Abstract][Full Text] [Related]
17. Alpha-S-GalCer: synthesis and evaluation for iNKT cell stimulation.
Blauvelt ML; Khalili M; Jaung W; Paulsen J; Anderson AC; Brian Wilson S; Howell AR
Bioorg Med Chem Lett; 2008 Dec; 18(24):6374-6. PubMed ID: 18993065
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapeutic potential for ceramide-based activators of iNKT cells.
Berkers CR; Ovaa H
Trends Pharmacol Sci; 2005 May; 26(5):252-7. PubMed ID: 15860372
[TBL] [Abstract][Full Text] [Related]
19. Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000.
Lacône V; Hunault J; Pipelier M; Blot V; Lecourt T; Rocher J; Turcot-Dubois AL; Marionneau S; Douillard JY; Clément M; Le Pendu J; Bonneville M; Micouin L; Dubreuil D
J Med Chem; 2009 Aug; 52(15):4960-3. PubMed ID: 19580320
[TBL] [Abstract][Full Text] [Related]
20. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
Hung JT; Huang JR; Yu AL
J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
